Ad-hoc announcement in compliance with § 15 WpHG

Frankfurt am Main | March 23, 2015

euromicron AG: Corrections to past consolidated statements in accordance with IAS 8 reduce equity capital – Publication of the annual and consolidated financial statements for 2014 to be postponed –Chairman of the Executive Board resigns from his position

In connection with the preparation of the 2014 IFRS consolidated financial statements for euromicron AG, errors that pertain to accounting and valuation of certain projects in the previous periods were discovered. Based on the information currently available, these errors made in the fiscal years 2012 and 2013 must be corrected in the consolidated financial statements for 2014 with no effect on profit or loss in accordance with IAS 8. The exact amount of the corrections is currently being calculated and will result in an equity capital reduction in the IFRS consolidated financial statements for 2014 most likely in the amount of approximately EUR 15 million. As of September 30, 2014, the group equity capital amounted to approximately EUR 126 million, which equates to an equity capital ratio of approx. 40%. The aforementioned corrections do not have any negative effects on the existing liquidity of the group. Furthermore, the company expects that all of the financial covenants agreed to with credit institutes will be fulfilled.

Group sales for 2014 will most likely lie within the projected corridor of between EUR 340 million and EUR 360 million. The EBITDA margin will be around the lower end of the projected range of between 6-8%.

In the HGB individual financial statement for the AG for the fiscal year 2014, the existing accumulated deficit will increase due to the fact that the previously mentioned corrections are to be processed under the current accounts under commercial law. Due to the expected accumulated loss in the HGB individual financial statement for euromicron AG 2014, no dividend payment for 2014 will be proposed to the Annual General Meeting.

Due to the ongoing reviews, the final figures for the fiscal year 2014 will not be published until April 30, 2015. Because of this delay, the Annual General Meeting will take place end of June 2015. The exact date will be announced well in advance.

The Chairman of the Executive Board of euromicron AG, Dr. Willibald Späth, has resigned today from his position as member of the Executive Board with immediate effect. The sole member of the Executive Board Thomas Hoffmann will attend to Dr. Späth’s responsibilities until further notice.

euromicron AG (www.euromicron.de) is an all-round solution provider for communications, transport, data and security. euromicron’s network infrastructures integrate voice, video and data transport wirelessly, via copper cable and by means of fiber-optic technologies. euromicron builds leading applications, such as security, control, healthcare or surveillance systems, on the basis of these cutting-edge network infrastructures.
Founded on its expertise as a developer and producer of fiber-optic components, euromicron AG is a strongly growing, highly profitable group that is listed on the stock market, has a medium-sized character and focuses on operational growth, integration and further market penetration, internationalization and expansion.

If you have any more questions, please contact

euromicron AG
Investor & Public Relations
Siemensstraße 6
63263 Neu-Isenburg
Germany
Phone: +49 69 631583-0
Fax: +49 69 631583-17
E-Mail: IR-PR@euromicron.de
WKN A1K030
ISIN DE000A1K0300

nach oben

RSS News Feeds

At the pulse of the digital future.
Keep up-to-date with our RSS feeds

Contact us

Tel.: +49 69 631583-0
Group Structure at a glance

Contact form

You want more information?
Fill out our contact form - quick and easy!